187660 — Hyundai ADM Bio lnc Balance Sheet
0.000.00%
- KR₩132bn
- KR₩134bn
- KR₩10bn
Annual balance sheet for Hyundai ADM Bio lnc, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14,700 | 30,770 | 35,070 | 18,974 | 5,843 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,465 | 3,905 | 4,159 | 4,979 | 4,204 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18,889 | 35,450 | 40,589 | 25,555 | 11,319 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 472 | 1,422 | 2,792 | 2,849 | 1,728 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,736 | 38,365 | 46,292 | 44,214 | 28,527 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,903 | 4,491 | 14,207 | 15,297 | 20,545 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,395 | 4,778 | 15,952 | 17,063 | 21,705 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 14,341 | 33,587 | 30,341 | 27,151 | 6,822 |
| Total Liabilities & Shareholders' Equity | 20,736 | 38,365 | 46,292 | 44,214 | 28,527 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |